N-terminal fatty acylated HiS-DPhe-Arg-Trp-NH2 tetrapeptides:: Influence of fatty acid chain length on potency and selectivity at the mouse melanocortin receptors and human melanocytes

被引:29
作者
Todorovic, A
Holder, JR
Bauzo, RM
Scott, JW
Kavanagh, R
Abdel-Malek, Z
Haskell-Luevano, C [1 ]
机构
[1] Univ Florida, Coll Pharm, Dept Med Chem, Gainesville, FL 32610 USA
[2] Univ Cincinnati, Coll Med, Dept Dermatol, Cincinnati, OH 45267 USA
关键词
D O I
10.1021/jm0490843
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The melanocortin system is involved in the regulation of a diverse number of physiologically important pathways including pigmentation, feeding behaviour, weight and energy homeostasis, inflammation, and sexual function. All the endogenous melanocortin agonist ligands possess the conserved His-Phe-Arg-Trp tetrapeptide sequence that is postulated to be important for melanocortin receptor molecular recognition and stimulation. Previous studies by our laboratory resulted in the discovery that increasing alkyl chain length at the N-terminal "capping" region of the His-DPhe-Arg-Trp-NH2 tetrapeptide resulted in a 100-fold increased melanocortin receptor agonist potency. This study was undertaken to systematically evaluate the pharmacological effects of increasing N-capping alkyl chain length of the CH3(CH2),CO-His-(D)Phe-Arg-Trp-NH2 (n = 6-16) tetrapeptide template. Twelve analogues were synthesized and pharmacologically characterized at the mouse melanocortin receptors MC1R and MC3R-MC5R and human melanocytes known to express the MC1R. These peptides demonstrated melanocortin receptor selectivity profiles different from those of previously published tetrapeptides. The most notable results of enhanced ligand potency (20- to 200-fold) and receptor selectivity were observed at the MC1R. Tetrapeptides that possessed greater than nine alkyl groups were superior to alpha-MSH in terms of the stimulation of human melanocyte tyrosinase activity. Additionally, the n-pentadecanoyl derivative had a residual effect on tyrosinase activity that existed for at least 4 days after the peptide was removed from the human melanocyte culture medium. These data demonstrate the utility, potency, and residual effect of melanocortin tetrapeptides by adding N-terminal fatty acid moieties.
引用
收藏
页码:3328 / 3336
页数:9
相关论文
共 70 条
[31]   MELANOTROPIC PEPTIDES FOR THERAPEUTIC AND COSMETIC TANNING OF THE SKIN [J].
HADLEY, ME ;
SHARMA, SD ;
HRUBY, VJ ;
LEVINE, N ;
DORR, RT .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1993, 680 :424-439
[32]   BIOLOGICAL-ACTIVITIES OF MELANOTROPIC PEPTIDE FATTY-ACID CONJUGATES [J].
HADLEY, ME ;
ALOBEIDI, F ;
HRUBY, VJ ;
WEINRACH, JC ;
FREEDBERG, D ;
JIANG, JW ;
STOVER, RS .
PIGMENT CELL RESEARCH, 1991, 4 (04) :180-185
[33]   Characterization of melanocortin NDP-MSH agonist peptide fragments at the mouse central and peripheral melanocortin receptors [J].
Haskell-Luevano, C ;
Holder, JR ;
Monck, EK ;
Bauzo, RM .
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (13) :2247-2252
[34]   Biological and conformational examination of stereochemical modifications using the template melanotropin peptide, Ac-Nle-c[Asp-His-Phe-Arg-Trp-Ala-Lys]-NH2, on human melanocortin receptors [J].
HaskellLuevano, C ;
Nikiforovich, G ;
Sharma, SD ;
Yang, YK ;
Dickinson, C ;
Hruby, VJ ;
Gantz, I .
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (11) :1738-1748
[35]   beta-methylation of the Phe(7) and Trp(9) melanotropin side chain pharmacophores affects ligand-receptor interactions and prolonged biological activity [J].
HaskellLuevano, C ;
Toth, K ;
Boteju, L ;
Job, C ;
Castrucci, AMD ;
Hadley, ME ;
Hruby, VJ .
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (17) :2740-2749
[36]   Characterizations of the unusual dissociation properties of melanotropin peptides from the melanocortin receptor, hMC1R [J].
HaskellLuevano, C ;
Miwa, H ;
Dickinson, C ;
Hadley, ME ;
Hruby, VJ ;
Yamada, T ;
Gantz, I .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (02) :432-435
[37]   Characterization of aliphatic, cyclic, and aromatic N-terminally "capped" His-D-Phe-Arg-Trp-NH2 tetrapeptides at the melanocortin receptors [J].
Holder, JR ;
Marques, FF ;
Xiang, ZM ;
Bauzo, RM ;
Haskell-Luevano, C .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2003, 462 (1-3) :41-52
[38]   Structure-activity relationships of the melanocortin tetrapeptide Ac-His-DPhe-Arg-Trp-NH2 at the mouse melanocortin receptors.: 1.: Modifications at the His position [J].
Holder, JR ;
Bauzo, RM ;
Xiang, ZM ;
Haskell-Luevano, C .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (13) :2801-2810
[39]   Structure-activity relationships of the melanocortin tetrapeptide Ac-His-DPhe-Arg-Trp-NH2 at the mouse melanocortin receptors:: Part 2 modifications at the Phe position [J].
Holder, JR ;
Bauzo, RM ;
Xiang, ZM ;
Haskell-Luevano, C .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (14) :3073-3081
[40]   ALPHA-MELANOTROPIN - THE MINIMAL ACTIVE SEQUENCE IN THE FROG-SKIN BIOASSAY [J].
HRUBY, VJ ;
WILKES, BC ;
HADLEY, ME ;
ALOBEIDI, F ;
SAWYER, TK ;
STAPLES, DJ ;
DEVAUX, AE ;
DYM, O ;
CASTRUCCI, AMD ;
HINTZ, MF ;
RIEHM, JP ;
RAO, KR .
JOURNAL OF MEDICINAL CHEMISTRY, 1987, 30 (11) :2126-2130